Hamostaseologie 2018; 38(02): 112-120
DOI: 10.5482/HAMO-17-01-0004
Case report
Schattauer GmbH Stuttgart

Characterization and Diagnostic Work-up of a Patient with Functionally Impaired Platelet GP6

Verena Klümpers
1   Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg – Hessen, Mannheim Germany
,
Isabelle Müller
2   Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and Saarland University Medical Center, 66421 Homburg, Germany
,
Peter Hellstern
3   Center of Hemostasis and Thrombosis, Zurich, Switzerland
,
Torsten J. Schulze
1   Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg – Hessen, Mannheim Germany
,
Christine Mannhalter
4   Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
,
Peter Bugert
1   Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg – Hessen, Mannheim Germany
,
Hermann Eichler
2   Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and Saarland University Medical Center, 66421 Homburg, Germany
› Author Affiliations
Further Information

Publication History

23 January 2017

16 August 2017

Publication Date:
29 May 2018 (online)

Zoom Image

Introduction

Platelet function assays are commonly used diagnostic tools in patients with suspected inherited or acquired hemostatic disorders, and to monitor the efficacy of anti-platelet medication.[1] [2] Beside different newer point-of-care assays, such as the platelet function analyzer (PFA) or the whole blood aggregometry (WBA),[3] [4] the classical Born's light transmission platelet aggregometry (LTA) is an indispensable diagnostic tool for hemostaseologists and therefore still frequently performed in specially equipped laboratories.[5] For routine testing of platelet function by the LTA assay, the patient's platelet rich plasma (PRP) is mixed with different platelet activating agonists, such as ristocetin, ADP, collagen, and arachidonic acid.[5] In few patients, testing their PRP by the LTA assay leads to an isolated missing response in the collagen-induced aggregation, while the platelets respond normally to all the other agonists.[6] [7] [8] Regarding the collagen-induced aggregation, the platelet membrane glycoprotein VI (GP6) plays a central role.[9] [10] It is expressed as a complex with the Fc receptor γ-chain (FcRγ) and has been identified as the main physiological platelet receptor for collagen.[11] When collagen binds to GP6, an activation cascade is initiated by tyrosine phosphorylation inducing the formation of a complex of signal-transducing proteins.[11] The collagen/GP6 interaction finally leads to a physiologic activation of platelets, which can be measured in vitro by the formation of platelet aggregates from PRP. On the other hand, in patients with bleeding tendency displaying a negative collagen reaction in the LTA assay but positive results for all other agonists including arachidonic acid, an acquired or inherited functional defect of GP6 could be the possible cause of the bleeding disorder.[12] [13] [14] [15] [16]

In this case report of a female patient suffering from a clinically mild bleeding disorder, we describe the complexity of the respective diagnostic work-up to elucidate a suspected functional GP6 defect.